A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1994
11/24/1994	WO1994026240A1 Composition for the treatment of impaired hair growth
11/24/1994	WO1994026233A1 Novel materials and methods utilizing a temporary visual indicator
11/24/1994	WO1994026208A1 Methods and formulations for use in treating oophorectomized women
11/24/1994	WO1994026186A1 Medical probe with stylets
11/24/1994	WO1994026130A1 Cholesterol lowering drink mix compositions
11/24/1994	WO1994026113A2 Pour-on formulations containinng polymeric material, glycols and glycerides
11/24/1994	WO1994026110A1 Stable quinolone and naphthyridine premix formulations
11/24/1994	WO1994026103A1 Organ preservative
11/24/1994	WO1994022441A3 Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
11/24/1994	WO1994022413A3 Triazole substituted quinoline derivatives
11/24/1994	WO1994016709A3 Therapeutic uses and delivery systems of dehydroepiandrosterone
11/24/1994	WO1994016073A3 Methods and reagents for inhibiting furin endoprotease
11/24/1994	DE4317449A1 Pharmaceutical composition for the treatment of disorders of the gastrointestinal tract
11/24/1994	DE4317173A1 Use of dihydrolipoic acid as ophthalmologic agent and for suppressing incompatibility reaction in the boundary region of implants with living body tissue
11/24/1994	DE4316727A1 Composition for the treatment of inflammatory disorders of the lower colonic region and of the skin with beclomethasone as active ingredient
11/24/1994	DE4316726A1 Composition for the treatment of cutaneous disorders with hydrocortisone acetate as active ingredient
11/24/1994	CA2500213A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	CA2455985A1 Therapeutic inhibitor of vascular smooth muscle cells
11/24/1994	CA2163255A1 Compositions in the form of solid solutions
11/24/1994	CA2163234A1 Inhibition of proliferation of vascular smooth muscle cell
11/24/1994	CA2163129A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	CA2163095A1 Treatment process with biologically active tropane derivatives
11/24/1994	CA2163004A1 Guanidine derivatives as inhibitors of na+/h+ exchange in cells
11/24/1994	CA2163001A1 Derivatives of .beta.,.beta.-dimethyl-4-piperidineethanamine as inhibi tors of the cholesterol biosynthesis
11/24/1994	CA2162990A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	CA2162868A1 Methods and compositions for detecting and treating mycobacterial infections using an inha gene
11/24/1994	CA2162724A1 Medical probe with stylets
11/24/1994	CA2162703A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	CA2162702A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	CA2162663A1 Oral compositions
11/24/1994	CA2162602A1 Gene transfer into pancreatic and biliary epithelial cells
11/24/1994	CA2162601A1 Inhibition of expression of beta-lactamase using esters of fatty acid alcohols
11/24/1994	CA2162574A1 Acyclovir derivatives for topical use
11/24/1994	CA2162556A1 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/24/1994	CA2162496A1 Allogeneic and xenogeneic transplatation
11/24/1994	CA2162478A1 Sialyl lex analogues as inhibitors of cellular adhesion
11/24/1994	CA2162272A1 Vitamin d amide derivatives
11/24/1994	CA2162023A1 [1,2,4]triazolo[4,3-a]quinoxaline compounds, their preparation and use
11/24/1994	CA2161978A1 Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton
11/24/1994	CA2161787A1 Fibrinogen receptor antagonists
11/24/1994	CA2161777A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994	CA2161702A1 Pyrimidine derivatives
11/24/1994	CA2161648A1 Compositions and methods for reparation and prevention of fibrotic lesions
11/24/1994	CA2161334A1 Hiv protease inhibitors useful in the treatment of aids
11/24/1994	CA2161021A1 Thioindole pyperidinyl derivatives used as antalgics
11/24/1994	CA2160786A1 Ras farnesyl transferase inhibitors
11/24/1994	CA2160776A1 Transdermal therapeutic systems for the administration of serotonin agonists
11/24/1994	CA2160124A1 Optically active 3-(1-(alkylamino)) alkyl pyrrolidines
11/24/1994	CA2140260A1 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity
11/24/1994	CA2139503A1 Compounds for cancer imaging and therapy
11/24/1994	CA2139332A1 Carbostyril derivatives
11/24/1994	CA2136303A1 Improved antiandrogens
11/23/1994	EP0625523A1 Cis-oxalato(trans-L-1,2-cyclohexanediamine) Pt(II) complex having high optical purity and process of preparing same
11/23/1994	EP0625517A1 Taxane having antitumor activity
11/23/1994	EP0625516A1 Benzenesulphonamide derivatives for the treatment of bladder instability
11/23/1994	EP0625514A1 2-Amino-pyrazin-5-carboxamid derivatives, their preparation and their use in therapy
11/23/1994	EP0625511A1 Heterocyclic compounds and their use in pharmaceutical
11/23/1994	EP0625509A1 N-alkyl substituted piperidine-derivatives with neurokinin receptor antagonist activity
11/23/1994	EP0625355A1 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient
11/23/1994	EP0625353A1 Slow-release pharmaceutical composition containing a bile acid as an active ingredient
11/23/1994	EP0625352A1 Use of Z-acetylpyridine for the manufacture of a medicament for suppressing smoking
11/23/1994	EP0625351A1 Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy
11/23/1994	EP0625313A1 High-calorie, low-osmolarity solution for total parenteral nutrition via periperal-venous administration
11/23/1994	EP0625207A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr)
11/23/1994	EP0625204A1 Hepatitis therapeutics
11/23/1994	EP0625203A1 Synthetic haemophilus influenzae conjugate vaccine
11/23/1994	EP0625194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide.
11/23/1994	EP0625192A1 Nucleozymes
11/23/1994	EP0625166A1 Sulphated polysaccharides, preparation thereof, pharmaceutical composition and use thereof.
11/23/1994	EP0625158A1 Therapeutic nucleosides
11/23/1994	EP0625156A1 [3H,7H]THIAZOLE[3,4-a]PYRIDINES HAVING ANTIASTHMATIC AND ANTIINFLAMNATORY ACTIVITIES ON THE RESPIRATORY TRACT
11/23/1994	EP0625155A1 Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
11/23/1994	EP0625153A1 Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
11/23/1994	EP0625151A1 Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
11/23/1994	EP0625150A1 1,3-oxathiolane nucleoside analogues
11/23/1994	EP0625149A1 Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
11/23/1994	EP0625148A1 Novel baccatine iii and 10-deacetyl baccatine iii derivatives, their preparation, and pharmaceutical compositions containing same
11/23/1994	EP0625145A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists
11/23/1994	EP0625144A1 Pyridone derivatives, their preparation and use as medicines
11/23/1994	EP0625143A1 Pyridine derivatives, their preparation and use as medicines
11/23/1994	EP0625138A1 Novel amidine derivatives, their preparation and their use as mediaments with ltb-4 antagonistic effect
11/23/1994	EP0625068A1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them
11/23/1994	EP0625055A1 Use of fullerenes in diagnostic and/or therapeutic agents
11/23/1994	EP0625045A1 Methods of treating inflammatory dermatoses
11/23/1994	EP0625044A1 Compositions for nasal administration containing polar metabolites of opioid analgesics
11/23/1994	EP0625007A1 Gene transfer in birds by introduction of dna into muscle in ovo
11/23/1994	EP0573492B1 Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts
11/23/1994	EP0549666B1 Novel aminobenzosultam derivatives as lipoxygenase inhibitors
11/23/1994	EP0545966B1 New phospholipid derivatives of nucleosides, their preparation and their use as antiviral drugs
11/23/1994	EP0543892B1 N-(mercaptoalkyl)ureas and carbamates
11/23/1994	EP0532565B1 STARTING COMPOUNDS FOR THE PRODUCTION OF 10$g(b)-H STEROIDS AND PROCESS FOR PRODUCING SUCH STARTING COMPOUNDS
11/23/1994	EP0522013B1 Novel vitamin d analogues
11/23/1994	EP0429464B1 Bivalent ligands effective for blocking acat enzyme
11/23/1994	CN1095417A Improvements in or relating to organic compounds
11/23/1994	CN1095416A Hispidospermidin
11/23/1994	CN1095415A The use of polyether ionophore antibiotics to control bacterial growth in alcohol fermentation
11/23/1994	CN1095383A Substituted 6-azaandrostenones
11/23/1994	CN1095382A Compounds
11/23/1994	CN1095380A Novel triazoloquinazolines, their preparation and use
11/23/1994	CN1095378A 3-(6-Qinolylmethyl)-4H-imidazol-4-one derivatives, their preparation and their application in therapy

1 ... 7064 7065 7066 7067 7068 7069 7070 7071 7072 7073 7074 7075 7076 7077 7078 7079 7080 7081 7082 7083 7084 ... 7860